
Fermenta Biotech Files FY26 Business Responsibility and Sustainability Report
Fermenta Biotech Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26. The report, which forms part of the Annual Report, is available on the company's website. Fermenta emphasizes that responsible business practices and sustainability are core to its work ethics and governance, aligning with environmental, social, and governance norms. The company's primary business activity is the manufacturing of Active Pharmaceutical Ingredients, Aqua CHL, Biotechnology, and Nutraceutical products, accounting for 96.4% of its turnover. Key products include Vitamin D3, with exports contributing 58% of the total turnover. The report details operational locations, markets served, employee statistics, and commitments to responsible business conduct.
Key Highlights
- Fermenta Biotech submits FY26 BRSR, integrating ESG into core strategy.
- Manufacturing of APIs, Biotech, and Nutraceuticals drives 96.4% of turnover.
- Exports constitute a significant 58% of the company's total turnover.
- Report details operations, markets, and employee data for FY25-26.
- Company adheres to National Guidelines for Responsible Business Conduct.
Price Impact
More from FERMENTA
More in ESG